Clinical Trial Update: Nuedexta for the Prevention and Modification of Disease Progression in Episodic Migraine [Phase 2]

View source ↗

Summary

Phase 2 trial results for Nuedexta (dextromethorphan/quinidine) evaluating prevention and modification of disease progression in episodic migraine; the study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• NUEDEXTA (DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE)

Snippet

Sponsor: Cady, Roger, M.D. | Conditions: Episodic Migraine | Phase 2 | Status: COMPLETED | Results posted: 2018-04-03